Wistar Institute enters agreement with Christiana Care Graham Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE WISTAR INSTITUTE has entered into an agreement with the Gene Editing Institute at Christiana Care’s Helen F. Graham Cancer Center & Research Institute, expanding their previous partnership established in 2011.

The Gene Editing Institute will be integrated into Wistar’s Molecular Screening Facility. The Gene Editing Institute will retain its management structure and will remain located at the Graham Cancer Center on the Christiana Hospital Campus in Newark, Del. The Molecular Screening Facility will remain housed at Wistar in Philadelphia. According to the two organizations, they have already begun scientific collaborations involving research on melanoma and lung cancer. The previous partnership was the first inter-institutional affiliation between an NCI-designated basic research institution and a community cancer center.

YOU MAY BE INTERESTED IN

Multiple components of the healthcare and public health systems are currently under scrutiny. One of them is reportedly the U.S. Preventive Services Task Force (USPSTF: “Task Force”), established in 1984 and managed by the Agency for Healthcare Research and Quality.  It was created to maintain an ongoing evaluation of disease prevention and screening interventions that...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login